HSY vs TSHA · P/E 36, rev $5.89B vs $640.7M cap
Hershey Co (HSY) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Hershey Co (HSY) is a confectioners company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported HSY revenue for 2026-06-28 was $5.89B. Net income was $892.8M. Revenue was up 89.8% from 2026-03-29 to 2026-06-28. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
HSY currently screens at market cap $39.36B and trailing P/E 36.1. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the HSY and TSHA stock pages for the full models.
Not investment advice.